Vokanamet: Metformin/Canagliflozin Combo Approved in EUVokanamet: Metformin/Canagliflozin Combo Approved in EU

A single pill combining metformin with the SGLT-2 inhibitor canagliflozin, named Vokanamet, has been approved for the treatment of type 2 diabetes in Europe. International Approvals
Source: Medscape Diabetes Headlines - Category: Endocrinology Tags: Diabetes & Endocrinology News Alert Source Type: news